The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Ngan, David A ^a   Wilcox, Pearce G ^a   Aldaabil, May ^a   Li, Yuexin ^a   Leipsic, Jonathon A ^a   Sin, Don D ^a   Man, S F P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCL18 PROTEIN; GRANZYME B; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; BETA CHEMOKINE; BIOLOGICAL MARKER; CARRIER PROTEIN; CCL18 PROTEIN, HUMAN; GRANZYME; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATION; LIMULUS LYSATE TEST; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT DISEASE; SPIROMETRY; SPUTUM CULTURE; ADOLESCENT; BLOOD; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS INFECTION; RISK FACTOR; SPUTUM; STATISTICS;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARRIER PROTEINS; CHEMOKINES, CC; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; GRANZYMES; HOSPITALIZATION; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RISK FACTORS; SPIROMETRY; SPUTUM;

EID: 84857000155     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-3     Document Type: Article

References (21)

1. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry: 2009 Annual Data Report. 2011, Bethesda, MD, Cystic Fibrosis Foundation.
2. Shead EF, Haworth CS, Barker H, Bilton D, Compston JE. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros 2010, 9(2):93-98. 10.1016/j.jcf.2009.11.007, 20006563.
3. Elborn JS. How can we prevent multisystem complications of cystic fibrosis?. Semin Respir Crit Care Med 2007, 28(3):303-311. 10.1055/s-2007-981651, 17562500.
4. Haworth CS, Selby PL, Webb AK, Martin L, Elborn JS, Sharples LD, Adams JE. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 2004, 59(7):613-617. 10.1136/thx.2003.012047, 1747064, 15223873.
5. Ionescu AA, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, Chatham K, Shale DJ. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000, 162(3 Pt 1):789-794.
6. Konstan MW, Wagener JS, VanDevanter DR. Characterizing aggressiveness and predicting future progression of CF lung disease. J Cyst Fibros 2009, 8(Suppl 1):S15-9.
7. Nick JA, Chacon CS, Brayshaw SJ, Jones MC, Barboa CM, St Clair CG, Young RL, Nichols DP, Janssen JS, Huitt GA, Iseman MD, Daley CL, Taylor-Cousar JL, Accurso FJ, Saavedra MT, Sontag MK. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 2010, 182(5):614-626. 10.1164/rccm.201001-0092OC, 2937235, 20448091.
8. Downey DG, Martin SL, Dempster M, Moore JE, Keogan MT, Starcher B, Edgar J, Bilton D, Elborn JS. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Pediatr Pulmonol 2007, 42(3):216-220. 10.1002/ppul.20553, 17238189.
9. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990, 116(5):714-719. 10.1016/S0022-3476(05)82653-8, 2109790.
10. Olesen HV, Holmskov U, Schiotz PO, Sorensen GL. Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis. J Cyst Fibros 2010, 9(4):257-262. 10.1016/j.jcf.2010.03.011, 20457545.
11. Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, Celedon JC, Pier GB, Weiss ST. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 2007, 42(3):256-262. 10.1002/ppul.20563, 17245735.
12. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998, 132(4):589-595. 10.1016/S0022-3476(98)70344-0, 9580754.
13. American Thoracic Society Standardization of spirometry--1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987, 136(5):1285-1298. American Thoracic Society.
14. Hieshima K, Imai T, Baba M, Shoudai K, Ishizuka K, Nakagawa T, Tsuruta J, Takeya M, Sakaki Y, Takatsuki K, Miura R, Opdenakker G, Van Damme J, Yoshie O, Nomiyama H. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol 1997, 159(3):1140-1149.
15. Persson A, Chang D, Rust K, Moxley M, Longmore W, Crouch E. Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry 1989, 28(15):6361-6367. 10.1021/bi00441a031, 2675969.
16. Kronborg G, Hansen MB, Svenson M, Fomsgaard A, Hoiby N, Bendtzen K. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr Pulmonol 1993, 15(5):292-297. 10.1002/ppul.1950150506, 8327288.
17. Rayner RJ, Wiseman MS, Cordon SM, Norman D, Hiller EJ, Shale DJ. Inflammatory markers in cystic fibrosis. Respir Med 1991, 85(2):139-145. 10.1016/S0954-6111(06)80292-1, 1887131.
18. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004, 172(7):4470-4479.
19. Tamagawa E, Suda K, Wei Y, Xing L, Mui T, Li Y, van Eeden SF, Man SF, Sin DD. Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immun 2009, 15(4):251-258. 10.1177/1753425909104782, 19587000.
20. Murphy DB, Cregg N, Tremblay L, Engelberts D, Laffey JG, Slutsky AS, Romaschin A, Kavanagh BP. Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin. Am J Respir Crit Care Med 2000, 162(1):27-33.
21. Chmiel JF, Konstan MW, Knesebeck JE, Hilliard JB, Bonfield TL, Dawson DV, Berger M. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. Am J Respir Crit Care Med 1999, 160(6):2040-2047.